Merck Stops Developing Both Of Its COVID-19 Vaccine Candidates
Merck, which previously made an Ebola vaccine, had been seen as a serious contender in the worldwide race to come up with an answer to the coronavirus.(Image credit: Budrul Chukrut/SOPA Images/LightRocket via Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - January 25, 2021 Category: Consumer Health News Authors: Bill Chappell Source Type: news
Johnson & Johnson ’s 1-Shot COVID-19 Vaccine Shows Promise in Early-Stage Trials
Johnson & Johnson’s experimental one-shot Covid-19 vaccine generated a long-lasting immune response in an early safety study, providing a glimpse at how it will perform in the real world as the company inches closer to approaching U.S. regulators for clearance.
More than 90% of participants made immune proteins, called neutralizing antibodies, within 29 days after receiving the shot, according to the report, and all participants formed the antibodies within 57 days. The immune response lasted for the full 71 days of the trial.
“Looking at the antibodies, there should be good hope and good reason that the va...
Source: TIME: Health - January 14, 2021 Category: Consumer Health News Authors: Riley Griffin / Bloomberg Tags: Uncategorized COVID-19 overnight wire Source Type: news
Johnson & Johnson COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published in New England Journal of Medicine
January 13, 2021 -- Interim Phase 1/2a data were published today in the New England Journal of Medicine demonstrating that the Company’s single-dose investigational COVID-19 vaccine candidate (JNJ-78436735) – being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson – provided an immune response that lasted for at least 71 days, the duration of time measured in this study in participants aged 18-55 years. A preview of part of these interim data was posted on medRxiv in September 2020.The Phase 1/2a interim analysis showed that the Company’s COVID-19 vaccine candidate induced an immune respons...
Source: Johnson and Johnson - January 13, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
WHO and Partners to Stockpile Ebola Vaccine
TUESDAY, Jan. 12, 2021 -- Ebola vaccines are being stockpiled by the World Health Organization and other groups to combat future outbreaks of the deadly disease.
An emergency reserve of about 500,000 doses of a Merck vaccine will be established,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 12, 2021 Category: Pharmaceuticals Source Type: news
Africa: UN Agencies, Partners Establish Global Ebola Vaccine Stockpile
[UN News] In a major milestone in the fight against deadly diseases, United Nations agencies and humanitarian partners announced on Tuesday, the establishment of a global Ebola vaccine stockpile, to help control future epidemics by ensuring timely access to vaccines for populations at risk, during outbreaks. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 12, 2021 Category: African Health Source Type: news
Ebola vaccines stockpiled against future outbreaks
The World Health Organization and partners say they are creating a global stockpile of Ebola vaccines to help stamp out future outbreaks (Source: ABC News: Health)
Source: ABC News: Health - January 12, 2021 Category: Consumer Health News Tags: Health Source Type: news
UN agencies, partners establish global Ebola vaccine stockpile
In a major milestone in the fight against deadly diseases, United Nations agencies and humanitarian partners announced on Tuesday, the establishment of a global Ebola vaccine stockpile, to help control future epidemics by ensuring timely access to vaccines for populations at risk, during outbreaks. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - January 12, 2021 Category: International Medicine & Public Health Source Type: news
UN agencies and partners establish global Ebola vaccine stockpile
In a major milestone in the fight against deadly diseases, United Nations agencies and humanitarian partners announced on Tuesday, the establishment of a global Ebola vaccine stockpile, to help control future epidemics by ensuring timely access to vaccines for populations at risk, during outbreaks. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - January 12, 2021 Category: International Medicine & Public Health Source Type: news
The Oxford-AstraZeneca Vaccine Approval May Be the Most Globally Important Yet
The COVID-19 vaccine developed by the University of Oxford and AstraZeneca wasn’t the first to be OK’d by regulators in the U.K.—health officials authorized the Pfizer-BioNTech jab nearly four weeks earlier. And it’s not the most effective—Stage 3 clinical trials suggest it prevents COVID-19 symptoms about 70% of the time vs. about 95% for the Pfizer vaccine and a similar one from Moderna (which is authorized in the U.S., but not the U.K.).
But the greenlight from the British Medicines and Healthcare Products Regulatory Agency on Wednesday could be a big step toward bringing the COVID-19 pande...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Michael Zennie Tags: Uncategorized COVID-19 Explainer overnight Source Type: news
Why Africa ’s COVID-19 Outbreak Hasn’t Been as Bad as Everyone Feared
When COVID-19 initially blazed through Asia, Europe and then the United States, global public health experts worried that it could be catastrophic for Africa, with its crowded cities, poorly funded health sector and lack of testing facilities. The U.N. Economic Commission for Africa in April predicted up to 300,000 deaths this year if the virus couldn’t be contained on the continent. Yet it was the U.S, with its superior health system, that hit that grim milestone first, and so far, Africa has been largely spared the worst of the devastation experienced by the rest of the world. As of Dec. 29, the Africa Centres for ...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized COVID-19 Londontime Source Type: news
Uganda: Is Uganda Ready to Acquire the Covid-19 Vaccine?
[Monitor] The world's population, years over, has been affected by a number of viral diseases such a Ebola and Influenza which, in some cases, have caused millions of deaths. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 21, 2020 Category: African Health Source Type: news
Top Global Health Moments of 2020
By The Editorial Team,
IntraHealth International
Community Health Nurse Olivia Yeboah thoroughly washes her hands at the Akropong Clinic in Ghana. Photo by Emmanuel Attramah, PMI Impact Malaria/US President ' s Malaria Initiative.December 17, 2020If we wanted to, we could list a COVID-19 moment for every month of 2020. We all know that the onset of the coronavirus pandemic—first in China and then worldwide—overwhelmed news coverage this year. And with good reason. It’s the first large-scale global pandemic in 100 years. At the time this article was ...
Source: IntraHealth International - December 17, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: HIV & AIDS COVID-19 Nutrition Policy Advocacy Health Workforce Systems Nursing Midwifery 2020 Health Workers Source Type: news
We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure.
For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived.
We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news
Even the Pandemic Hasn ’t Made Public-Health Icon Paul Farmer Lose Hope
“Am I allowed to be a normal human and say, ‘How are you?'” asks Dr. Paul Farmer as soon as our Zoom call connects.
It’s an apt introduction for a man who became a living legend in the global health world mostly by being a normal human who does extraordinary things–starting with co-founding the Boston-based nonprofit organization Partners in Health (PIH) in 1987, before graduating from Harvard Medical School. Since then, PIH and its global staff of 18,000 have helped strengthen health systems in the “clinical deserts” of Haiti, Rwanda, Peru, Russia and numerous other countries. PIH...
Source: TIME: Health - December 3, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Magazine Public Health Second click Source Type: news
Cutting UK overseas aid could harm the fight against future pandemics | Matthew Baylis and Fiona Tomley
In our age of emerging pathogens, funding for global research into zoonotic diseases such as Covid-19, Ebola and Sars is vitalCoronavirus – latest updatesSee all our coronavirus coverageThis year, we ’ve seen how a previously unknown animal virus can spill over into the human population in one country, pass rapidly between people, and spread across the world in days. With nearly1.5m reported deaths from Covid-19, the virus is a startling indication of how the health of the world ’s human population is inseparable from animals and the environment that we share with them.Treating health in a way that recognises these i...
Source: Guardian Unlimited Science - December 2, 2020 Category: Science Authors: Matthew Baylis and Fiona Tomley Tags: Vaccines and immunisation Coronavirus Infectious diseases Microbiology Science Health World news Society Medical research Ebola Sars Aid UK news Source Type: news
